Efficacy and Safety of BoozLiv™ as an add on therapy in patients with alcoholic liver disease: An open-label, randomized controlled trial

Efficacy and Safety of BoozLiv™ as an add on therapy in patients with alcoholic liver disease: An open-label, randomized controlled trial

Background: Alcoholic Liver Disease (ALD) poses a significant global health threat, contributing to millions of deaths each year. Despite the well-established link between chronic alcohol consumption and liver damage, treatment options remain limited, emphasizing the need for innovative approaches....

Full description

Bibliographic Details
Main Authors: Mohammad Nezamuddin Khan, Balavigneshwaran A, Priyadharshini Ananthathandavan, Vijayakumar T M, Rajesh N A, Pavithra A, Sumitha A
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-10-01
Series:Gastroenterology & Endoscopy
Subjects:
BoozLiv™
erbal supplementation
Alcoholic liver disease
MELD
Phyllantuhusniruri
Hepatic parameters
Online Access:http://www.sciencedirect.com/science/article/pii/S2949752324000426

Internet

http://www.sciencedirect.com/science/article/pii/S2949752324000426

Similar Items